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Abstract
Even though Rwanda lies within a region that has a high prevalence of schistosomiasis and soil-transmitted
helminth (STH) infections, epidemiological information regarding these infections in the country remains scarce. The
present review attempts to compile the available data on schistosomiasis and STHs, from 1940 to 2014, to provide
an insight on the epidemiological profile of these infections. This information will, in turn, support the design and
implementation of sustainable control measures. The available records indicate that only Schistosoma mansoni and
all the major species of STHs are endemic in Rwanda. In 2008, the national prevalence of S. mansoni was reported
to be 2.7%, ranging from 0 to 69.5%, and that of STH infections was 65.8% (diagnosed using the Kato-Katz
technique). The prevalence of these infections varies from one district to another, with schoolchildren remaining a
highly affected group. The main control approach is mass drug administration using albendazole and praziquantel,
mostly targeting school-aged children in school environments. In 2008, adult individuals living in areas with a
prevalence of S. mansoni ≥30% were also included in the mass drug administration programme. However, despite
Rwanda achieving an almost 100% coverage of this programme in 2008–2010, the transmission of S. mansoni and
STHs continues to take place, as illustrated by the most recent surveys. If Rwanda is to achieve sustainable control
and elimination of schistosomiasis and STHs, there is a need to revise the country’s control strategy and adopt an
integrated control approach that involves a combination of measures.
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Introduction
Schistosomiasis remains one of the most prevalent
neglected tropical diseases (NTDs), causing significant
morbidity in Sub-Saharan Africa (SSA) [1–3]. Worldwide,
schistosomiasis is estimated to affect over 290 million
individuals [3], with more than 779 million individuals
living in high-transmission areas [1, 2]. Of the infected
individuals, 93% live in SSA [1, 2] and approximately 76%
live in high-transmission areas. An estimated 120 million
individuals have schistosomiasis-related symptoms and
the disease accounts for over 2.8 million years lived with
disabilities [3, 4]. School-aged children (SAC) harbour the
highest prevalence and intensity of schistosome infections,
while a lower intensity of infection is observed in adults
[1, 4]. In recent years, it has been reported that pre-
schoolchildren (PreSAC) from SSA are infected and carry
a high intensity of infection [1, 4]. The lower intensity of
infection observed in adults might be explained by behav-
ioural changes towards risk areas such as avoiding water
contacts or risk areas that come with an increase in age
and slower development of partial immunity [5–8]. How-
ever, in high-transmission areas and in areas with high fre-
quency of human water contact associated with economic
activities, a large number of both young adults and mature
adults are infected with the disease [6, 7].
In SSA, the most important species causing schisto-
somiasis are Schistosoma mansoni and S. haematobium
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[9]. S. mansoni causes intestinal schistosomiasis and its
chronic form is mainly characterised by bloody diar-
rhoea, bowel ulceration, hepatomegaly, periportal fibro-
sis that can lead to portal hypertension, oesophageal
varices and hematemesis [4, 9]. In SSA, around 8.5
million cases of chronic hepatosplenic schistosomiasis
disease are attributed to the S. mansoni infection [4, 10].
S. haematobium is the aetiological agent of urogenital
schistosomiasis and is primarily characterised by urinary
bladder pathology, haematuria, dysuria and hydronephrosis
[4, 9]. A previous study indicates that S. haematobium is
responsible for 10 million cases of hydronephrosis in SSA
[4]. Emerging evidence also reveals that urogenital schisto-
somiasis increases the risk of acquiring and transmitting
HIV, especially among women of reproductive age [11].
Similarly, soil-transmitted helminths (STHs) continue
to be a serious public health problem worldwide, with
more than 1.75 billion people estimated to be infected
[3, 12–14]. Of these, about 471 million, 477 million and
804 million are estimated to be infected with hook-
worms, Trichuris trichiura and Ascaris lumbricoides, re-
spectively [3]. These infections mainly affect the poorest
and most deprived communities, which are characterised
by poor sanitation [14]. Soil-transmitted helminths are
mainly prevalent in the rural areas of SSA, the Americas,
China and East Asia [14]. Pre-school and school-aged
children carry the highest prevalence and intensity of
STHs, with available data indicating that over 270
million PreSAC and over 600 million SAC live in areas
characterised by an intense transmission of these
parasites [1]. Another estimate indicates that between
one-quarter and one-third of the Sub-Saharan African
population is infected or co-infected by one or more
species of STHs [14]. The common STH species are
hookworms, A. lumbricoides and T. trichiura [15, 16].
Of the three STH species, hookworm infection appears
to be widely distributed in SSA, with an estimated 198
million people infected, of which 40–50 million are SAC
[1, 14, 17]. Similarly, A. lumbricoides and T. trichiura are
estimated to infect 173 million and 162 million individ-
uals, respectively, in SSA, with 81 million of those infected
being SAC [14]. In this group, these infections are associ-
ated with growth retardation, anaemia, decreased cogni-
tive function and increased school absenteeism [12].
Several attempts have been made to map the geograph-
ical distribution of schistosomiasis and STHs in various
countries in SSA (http://www.thiswormyworld.org/)
[18–20]. These maps remain important tools for planning,
resource allocating, implementing and evaluating control
programmes. However, these maps have a limitation in that
they cannot clearly predict micro-epidemiological features
and micro-distribution of these infections in remote areas
of the African continent [19]. For example, these maps
may not show the socio-economic factors that may
contribute to re-infection after treatment or persistence of
infections. Thus, a review of the available web-based and
grey literature on the micro-geographical and micro-
epidemiological distribution of these infections in various
countries, such as Rwanda, may provide supplementary in-
formation to guide control programmes at the local level.
Rwanda is a country in which the public health system
is still recovering from years of destruction as a result of
political problems, thus there is a paucity of information
on the geographical distribution and risk factors relating
to a number of tropical diseases, including schistosomia-
sis and STHs [21]. In recent years, there have been na-
tional, non-governmental organisation and international
community efforts to understand the epidemiology of
these infections. However, epidemiological information
generated by past and present surveys is not easily ac-
cessible via the public domain, and where information is
available it has not been updated and therefore cannot
be readily used for planning and implementing sustain-
able control programmes [21].
In the attempt to fill this gap, the present paper reviews
the available literature on the epidemiology and transmis-
sion of schistosomiasis and STHs in Rwanda, and high-
lights the strengths and weaknesses of control efforts. The
main objective is to provide an insight into the epidemio-
logical profile of these infections in Rwanda based on past
and recent surveys. This information is important for un-
derstanding the existing situation in relation to these in-
fections, tracking the trends across the different regions of
the country, and understanding the effect of control pro-
grammes on the prevalence and intensity of infections. In
addition, this information provides a framework for evalu-
ating the effects of the implemented control approaches
and the cost-effectiveness of interventions.
Method for literature search
The PubMed, Global Health and Google Scholar data-
bases were searched for original articles exploring the
epidemiology and control of schistosomiasis and STHs
in Rwanda.
The following combinations were used as keywords to
search for literature on schistosomiasis: ‘helminths’ and a
combination of the following words in permutations –
‘epidemiology + control + Rwanda’, ‘epidemiology +mass
drug administration + Rwanda’, ‘Schistosoma mansoni +
Rwanda’, ‘Schistosoma haematobium + Rwanda’ and
‘Biomphalaria/Bulinus + Rwanda’.
Similarly, for STHs, the following combinations were
used: ‘epidemiology +Ascaris’, ‘epidemiology +Trichuris +
Rwanda’, ‘epidemiology + hookworm + Rwanda’ and
‘epidemiology + Ascaris + control’.
Through this search, 10 publications on the prevalence
and intensity of infections and the impact of mass drug
administration (MDA) were identified. An additional
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search of the references identified two more papers. The
search specified only publications that were written in
the English language and covered a period from 1940
to 2014.
Epidemiology of schistosomiasis in Rwanda
Geographical distribution, prevalence and intensity of
infection
Historical epidemiological surveys have reported on the
transmission of schistosomiasis in Rwanda since the late
1940s [22]. Reports from 1947 indicate that Lakes Bulera
and Ruhondo, in Northern Rwanda, were the main
sources of infection [22]. In the mid-1970s and early
1980s, the transmission of intestinal schistosomiasis was
reported in many areas of the country, with the majority
of those infected being children aged 5–10 years [22].
Epidemiological surveys carried out by the Rwandan
Ministry of Health at the time noted that Lakes Ruhondo,
Bulera, Kivu, Muhazi, Rweru, Mugesera and the swampy
areas of Nyagatare district were potential areas for the
transmission of S. mansoni in the country (see Table 1)
[21, 23–26]. The lake basins and swampy areas are poten-
tial breeding sites of the snail intermediate hosts, which
contribute to the parasite’s life cycle [23]. Indeed, early
malacological studies identified the freshwater snails
Biomphalaria spp. as the intermediate hosts involved in
the transmission of S. mansoni in Rwanda [23]. This is
consistent with findings of 2012 from the Eastern Province
of the country, which revealed a high number of
Biomphalaria spp. infected with Schistosoma cercariae
[23]. There is a lack of information on the specific species
of Biomphalaria snails involved in the transmission of S.
mansoni in Rwanda, though one report indicated B.
pfeifferi as the main species transmitting the parasite
around Lake Ruhondo. The presence of Bulinus spp.
(freshwater snails that are intermediate hosts for S.
haematobium) were noted in 2012, but none of the snails
observed were infected with cercariae [23].
There is limited information on the prevalence and in-
tensity of the S. mansoni infection in Rwanda. Past epi-
demiological surveys in 1981 reported a prevalence of
6.5% along Lake Ruhondo in Northern Rwanda [22].
The results were based on a single faecal smear observa-
tion [22]. It should be mentioned that this study was cri-
ticised for not describing the laboratory technique used
to screen for S. mansoni infection [22].
In 2007, the Schistosomiasis Control Initiative (SCI),
in collaboration with Columbia University in the United
States, Geneva Global and the Global Network for
NTDs, with funding from the Legatum Group, initiated
an integrated NTD programme in Rwanda through the
Access Project, which aimed at mapping the distribution
of NTDs [21, 27]. A nationwide epidemiological survey,
which included 8 313 schoolchildren (aged 10–16 years)
from 136 schools in 30 districts, revealed that S. man-
soni was endemic in 18 districts, with prevalence rates
ranging from 10 to 50% in eight districts and over 50%
in two districts [21, 27, 28]. The overall national preva-
lence of S. mansoni based on the Kato-Katz diagnostic
technique was estimated to be 2.7%, with variations be-
tween school/districts ranging from 0 to 69.5% [21, 27]. In
this survey, although few cases of microhaematuria were
detected, no cases of S. haematobium infection were con-
firmed by the urine filtration technique [21, 27].
Epidemiological surveys in 2010 and 2015 conducted
in areas not previously included in the nationwide epi-
demiological surveys have exposed a higher prevalence
of S. mansoni infection in areas around Lake Rweru and
Nkombo Island [24, 25]. Along Lake Rweru, an epi-
demiological survey (based on the Kato-Katz diagnostic
technique) conducted among 270 SAC and adults re-
vealed a prevalence of 20.1%, with variations between
the study villages (ranging from 1.6% in Mujwiri to
30.1% in Mazane Island) [25]. The age-based classifica-
tion of the prevalence indicated that the age group 5–16
had the highest prevalence of the infection [25].
The initial national mapping survey in 2008 classified
the Rusizi district as an area with a low endemicity of S.
mansoni infection, however, a recent survey reported a
prevalence of 62.1% (based on the Kato-Katz diagnostic
technique) among 311 SAC aged 10–19 years on
Nkombo Island located in this district [24]. A variation
in prevalence between schools, ranging from 28.6 to
77.9%, was reported [24].
A recent systematic review and geostatistical analysis
reported an overall prevalence of 3.8% for S. mansoni
based on data that were available in 2012. The review
further indicated that an estimated 2.9 million, 299 000
and 30 000 individuals were living in areas characterised
by low, moderate and high risk for schistosomiasis
transmission [29].
In general, these findings clearly indicate that S.
mansoni is focally transmitted in Rwanda and that
prevalence of infection varies substantially from one
epidemiological setting to another. The variations in
prevalence may partly be explained by variations in the
geographical distribution of potential risk factors, such
as large water bodies, and differences in socio-economic
status among the communities living in areas with
different transmission intensities. In addition, the use of
the Kato-Katz technique, which is a less sensitive
method when used to diagnose infection among a lightly
infected population, may explain the observed variation
in prevalence. Thus, the use of more sensitive tech-
niques for mapping, such as the circulating cathodic
antigen, is highly recommended [30]. Figure 1 shows the
distribution pattern of S. mansoni and S. haematobium
in Rwanda.
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In relation to the intensity of infection, most surveys
have indicated that the majority of S. mansoni-infected in-
dividuals carry a light intensity of infection and only a few
are moderately or heavily infected [21, 24, 25, 27]. How-
ever, in areas with intense transmission such as Nkombo
Island and along the shores of large water bodies such as
Lakes Rweru and Muhazi, S. mansoni-infected individuals
are moderately or heavily infected [24, 25]. These findings
corroborate the findings reported elsewhere about S. man-
soni-endemic areas in SSA [31–33].
Geographical distribution, prevalence and
intensity of infection of soil-transmitted helminths
in Rwanda
Soil-transmitted helminths, which include A. lumbricoides,
A. duodenale (hookworm) and T. trichiura, are among the
Table 1 Epidemiological studies reporting on the prevalence and intensity of infection of schistosomiasis and STHs in Rwanda
Authors Parasites Major findings Geographical area
[23, 25] 2008 Soil-transmitted helminths-hookworm,
T.trichiura and A.lumbricoides
- S. mansoni and S.haematobium
A total of 8 313 randomly sampled school children
from 136 schools in 30 districts in Rwanda. Single stool
sample collected from each school child and processed
using Kato-Katz method and urine filtration test for
detection of S.mansoni and STH. Dipsticks and urine
filtration test were used for diagnosis of S. haematobium.
Six species of intestinal helminths were identified with
an overall STH infection prevalence of 65.8% with A.
lumbricoides (38.6%) and hookworms (31.6%) most
common. Co-infection of A. lumbricoides and Trichuris
trichiura was found to be particularly common
All geographical areas of Rwanda
S. mansoni and S.haematobium -S.mansoni was common along the large water bodies,
overall national prevalence was 2.7%, range from 0 to
69.5%.
- No cases of S.haematobium was detected.
[24] 1981 S.mansoni A total of 4 751 individuals aged 0- > 30 years were
examined single feacal smear on single stool sample.
Of these 107 (2.17%) from north and 69 (3.47%) had
S.mansoni infection.
Bulera south and north
A total of 5 739 individuals aged 0- > 30 years were
examined using single feacal smear on single stool
sample. Of these 5.9% (135) from north and 236 (6.8%)
had S. mansoni infection.
Note: No parasitological technique mentioned.




A total of 1 605 individuals, 1485 children aged 5-17
and 120 adolescent aged 18–20 years were screening
using Kato Katz techniques on duplicated thick smears
prepared from single stool sample. Of all the individuals,
0.25, 0.75, 2.8 and 6.04% were infected with S.mansoni,
hookworm, T.trichiura and A.lumbricoides. Almost 21.2%
were co-infected with A.lumbricoides and T.trichiura
parasites.
Lake Bulera and Ruhondo, Musanze
district
[27] 2010 S.mansoni A total of 270 individuals (children and adults) were
screened using duplicated Kato Katz thick smears
technique on single stool sample. Of these participants,
20.1% were infected with variation of prevalence
between villages ranging from 1.6 to 30.1%.
Lake Rweru, Bugesera district
STH The prevalence of hookworm was 33%, 22% for
T.trichiura and 12.2% for A.lumbricoides.
[29] 2015 S. mansoni A total of 311 school children from four primary school
were examined for presence of S.mansoni eggs using
Kato Katz technique on single stool sample. Overall,
62.1% of the children were infected with S.mansoni
infection. The overall feacal egg count (eggs per gram
of faeces) was 176.9 epg.
Nkombo island, Lake Kivu, Rusizi
district
[37] 2014 STH A total of 662 school children (301 from rural and 321
from urban) with median age of 10.2 years. Stool
sample were examined using Polymerase Chain
Reaction (PCR) and the overall prevalence of STH was
13% in urban and 38% in rural areas. A.lumbricoides
accounted for 95.6% of all detected helminths.
Butare and Huye district, southern
province
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common neglected tropical parasitic infections that occur
in Rwanda. These infections are known to affect PreSAC
and SAC [34, 35]. In 2007/8, the geographical distribution
of STH infections in Rwanda was reviewed through a
countrywide mapping among schoolchildren [21, 27]. A
total of 8 313 SAC from 136 primary schools in 30 districts
were included in the screening programme [21, 27]. The
overall prevalence of any STH was 65.8%, with a
prevalence of 38.6% for A. lumbricoides, 31.6% for A.
duodenale and 27% for T. trichiura [21, 27].
National surveys have shown a wide distribution of
STH infections in Rwanda with significant variations be-
tween districts [21, 27]. For instance, in Huye district
(Southern Province), in 2008, the prevalence of A.
lumbricoides was 61%, of hookworm it was 31% and of
T. trichiura it was 13% (see Table 1) [21]. There was also
Fig. 1 Distribution of schistosomiasis in Rwanda. Map shows maximum point prevalence of schistosome infections and locations of S. mansoni
and S. haematobium surveys in Rwanda. (http://www.thiswormyworld.org/maps/2013/distribution-of-schistosomiasis-survey-data-in-rwanda)
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a variation in the prevalence according to the diagnostic
methods used. For instance, when the polymerase chain
reaction technique was introduced as a method of diag-
nosis in the same district in 2014, the prevalence of A.
lumbricoides was reported to be 96% among 662 school-
children (see Table 1) [34].
In general, the national mapping of 2008 showed a
higher prevalence of A. lumbricoides and T. trichiura in
the western and northwestern part of the country,
whereas there was a high prevalence of hookworms in
the eastern part of the country. The observed variation
in distribution may partly be related to ecological differ-
ences (the eastern part being warmer and drier than the
western part) in the country. Figure 2 shows the distri-
bution pattern of STHs in Rwanda.
The comparison of the geographical distribution of
STHs between urban and rural areas indicates that the
majority of infections occur in rural areas in 2014
(prevalence of 38% in rural areas versus 13% in urban
areas) [34]. The variation in the level of sanitation and
hygiene may explain the observed difference in preva-
lence. The factors associated with the geographical varia-
tions in prevalence and the species of STHs in Rwanda
have not yet been thoroughly investigated. However,
these factors have been well described for other highly
endemic countries in Asia and SSA [14, 15].
Control of intestinal schistosomiasis and STHs
In 2007, through its Ministry of Health, Rwanda initiated
a control programme for NTDs with support from other
partners such as the SCI, Geneva Global, the Global
Network for NTDs, Colombia University and the Access
Project [21, 27, 36]. The main objective of the control
programme was to reduce the prevalence and mor-
bidities associated with STH infections (ascariasis, tri-
churiasis and hookworms) and schistosomiasis [36].
Other NTDs targeted were trachoma, lymphatic filariasis
and onchocerciasis [21]. To adequately plan a control
programme, particularly while using the MDA approach,
it became necessary to understand the precise dis-
tribution of these infections in the country. Thus, a
countrywide mapping exercise was undertaken between
2007 and 2008, whereby the endemic areas were
identified [21, 27].
Following the initial 2008 mapping, the first round of
MDA was implemented at the national level against
STHs in all districts; MDA against intestinal schistosom-
iasis was only implemented in areas with a prevalence
among SAC equal to or higher than 10% [36].
In the first three years of the MDA programme,
Rwanda administered over 18 million doses of
albendazole/mebendazole (ALB/MEB) against STHs to
an estimated 4.2 million individuals; this number cor-
responding to nearly half of the Rwandese population
(in 2010, the estimated total population was 10 277 212)
[37]. Figures 3 and 4 show the population that needed
treatment and that which was actually treated for the
period of 2008–2010 for schistosomiasis and 2005–2010
for STHs. Table 2, created using World Health
Organization (WHO) country epidemiological data on
NTDs, indicates that for the first round of ALB/MEB, the
MDA programme attained a 100% coverage, especially
among PreSAC and SAC [37]. In the same round of treat-
ment in 2008, a total of 201 116 SAC and adults received
a combination of ALB/MEB and praziquantel (PZQ) and
in 2009, 275 650 SAC received a combination of ALB/
MEB and PZQ against STHs and schistosomiasis [37]. In
2014, a total of 2 298 684 individuals were estimated to
require preventive chemotherapy for schistosomiasis; of
these 1 424 532 individuals were SAC. The MDA pro-
gramme achieved a programme coverage of 98.35% and a
national coverage of 7.6% (see Table 3) [38]. For STH in-
fections, with two rounds of MDA with ALB/MEB target-
ing PreSAC, the programme achieved a 96% programme
coverage and a 100% national coverage [38]. Similarly, the
MDA programme targeting SAC for two rounds achieved
98.35 and 95.26% programme coverage, and 7.51 and
100% national coverage, for Rounds 1 and 2, respectively
(see Table 3) [38].
The widespread treatment coverage resulted in high
cure rates in the treated children, especially against STH
infections [36]. For instance, in the Huye district, the
cure rate against STHs was 92% in 2014 and for A.
lumbricoides, it was 100% [34]. In 2008, administration
of one round of PZQ treatment to 2 166 schoolchildren
living in endemic districts resulted in a significant de-
crease in the prevalence of schistosomiasis, from 11.2%
at baseline to 2% at one-year follow-up [39]. Similarly, in
the same period, the intensity of infection decreased by
two folds from 72 eggs per gram of faeces (epg) to 36
epg [39]. Similarly, the prevalence of A. lumbricoides in-
fection in Huye district decreased from 61% during the
mapping period, to 38% in rural areas and 13% in urban
areas following two rounds of treatment [36].
However, despite achieving almost 100% coverage of
ALB/MEB and PZQ treatment in 2008, the transmission
of STHs and schistosomiasis continues to occur in dif-
ferent epidemiological settings [24, 25, 34, 35]. This not
only necessitates repeated treatment, but also the inte-
gration of other preventive measures into the MDA
programme.
Discussion
The available data indicate that Rwanda remains a highly
endemic area for STH and schistosome infections des-
pite the fact that the country has made significant efforts
in mapping and implementing control programmes, es-
pecially in the past 10 years. Despite achieving a wide
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coverage of the MDA programme, the transmission of
STHs and schistosomiasis remains a significant public
health problem. For instance, the transmission of STHs
in Huye district continues to occur despite two rounds
of MDA leading to significant cure rates [34]. The Huye
district was noted in the mapping programme as being a
highly affected area, with a prevalence of A. lumbricoides
reaching 92% pre-treatment [21, 27]. Similarly, the
transmission levels of S. mansoni was noted in 2015 as
being on the increase on Nkombo Island, in the Rusizi
district [24].
The persistent transmission of STHs and schistosom-
iasis, despite the annual MDA programme, calls for a
multisectoral approach for controlling these infections
[13]. Depending only on preventive chemotherapy as the
main control measure against STHs and schistosomiasis
Fig. 2 Distribution of STHs in Rwanda. The map shows the maximum point prevalence of STH infections and locations of STH surveys in
Rwanda. http://www.thiswormyworld.org/maps/by-worm/soil-transmitted-helminths
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may not reduce the transmission of these infections and
their related morbidity. The integration of other public
health interventions such as public health education fo-
cusing on behavioural changes and the introduction of
water, sanitation and hygiene (WASH) measures may
enhance the effect of MDA in controlling STHs and
schistosomiasis [13].
It has recently been prioritised to implement WASH
measures to complement the MDA programmes target-
ing STH infections in endemic settings [13]. The WASH
programme was introduced in Rwanda in 2011 with the
help of World Vision in an attempt to tackle water- and
hygiene-related diseases. Through the Rwanda WASH
programme, a large number of water points have been
created or restored, and hand washing and sanitation fa-
cilities have been availed to targeted rural communities.
However, so far little is known about the impact of
WASH efforts on the prevalence and intensity of schis-
tosomiasis and STH infections.
Importantly, designing and implementing an array of
public health measures requires an adequate understand-
ing of the local knowledge and perception of the affected
population concerning the infections that may affect them
[40, 41]. To date, only one study has investigated local
knowledge and perception of the communities towards
these infections in Rwanda [40]. Comprehending the
community level of knowledge and perception is a step to-
wards designing and implementing public health interven-
tion measures [13]. Several methods of public health
education have been designed and used in other endemic
countries and have resulted in an increased awareness and
adherence to control measures [42]. However, it has been
reported that public health education provided in the form
of posters or teaching aids did not result in changes in
knowledge and attitudes towards infections in specific
high-risk groups [43].
Between 2000 and 2010, integrated control measures
have been implemented in China against schistosomia-
sis, which included preventive chemotherapy, environ-
mental management, water and sanitation improvement
and public health education, have resulted in a signifi-
cant decrease in the prevalence rate of S. japonicum in-
fection to under 1% [44]. The WHO has repeatedly
emphasised the importance of integrating a set of public
health measures, such as the use of safe water, environ-
mental management, improving sanitation and public
health education focusing on behavioural changes, into
the MDA programme as part of the control measures
against STHs and schistosomiasis [37].
Fig. 3 Schistosomiasis treatment coverage for the period 2008–2009
among SAC in Rwanda. Preventive Chemotherapy (PC)- population
requiring preventive chemotherapy for schistosomiasis refers to
estimates of the number of children needing preventive chemotherapy
and the number of treatments for a given period. National coverage
refers to the proportion (%) of individuals in the population requiring
preventive chemotherapy against schistosomiasis who have
been treated
Fig. 4 Treatment coverage for STHs for the period 2005–2010 among SAC in Rwanda No data were available on treatment coverage and
national coverage for the period of 2005–2007 among SAC. Preventive Chemotherapy (PC)- population requiring preventive chemotherapy for
schistosomiasis refers to estimates of the number of children needing preventive chemotherapy and number of treatments for a given period.
National coverage refers to the proportion (%) of individuals in the population requiring preventive chemotherapy against schistosomiasis who
have been treated
Rujeni et al. Infectious Diseases of Poverty  (2017) 6:8 Page 8 of 11
The use of molluscicides (taking their environmental
and ecological impact into consideration), which target
intermediate host snails that transmit a larval form of
Schistosoma to the human population, is another ap-
proach that can be used on a small scale to reduce or
stop the transmission of schistosome infections. How-
ever, in Rwanda, information is scarce on the distribu-
tion of the intermediate host snails responsible for
transmitting S. mansoni infection [23], with a few studies
implicating the genus Biomphalaria [23]. Thus, as the
geographical remapping of STHs, schistosomiasis and
other NTDs is underway in Rwanda, there is also a need
to identify potential intermediate host snails involved in
the life cycle of the parasite and to map potential areas
for transmission that can be targeted by molluscicides.
Studying the physical chemical properties of water
bodies with high numbers of snails, as well as aquatic
vegetation on which the snails attach, would also be in-
valuable in predicting high-risk areas. Historical reviews
have indicated the importance of molluscicides and
suggest that informed snail control can be an effective
means of reducing local transmission [45, 46]. In fact,
these reviews indicated that widespread snail control
using molluscicides has reduced schistosomiasis preva-
lence in programmes incorporating little or no snail con-
trol, respectively [45, 46]. When properly implemented,
snail control using molluscicides can complement MDA
and reduce rates of re-infection [45, 46].
Conclusion
Overall, STHs and intestinal schistosomiasis are endemic
in Rwanda. While STHs are widely distributed in the
country with varying prevalence rates, intestinal schisto-
somiasis is focally distributed and only endemic along
large water bodies. The country has made efforts to
understand the distribution of these infections through
countrywide geographical mapping using SAC as the
main infected group.
The countrywide MDA programme has resulted in a de-
creased prevalence and intensity of STH and schistosome
Table 2 Implementation of preventive chemotherapy for the period 2006–2010 using ALB/MEB against STHs among PreSAC and
SAC in Rwanda
2006 2007 2008 2009 2010
PreSAC PreSAC PreSAC/SAC PreSAC/SAC PreSAC/SAC
Round 1
Population targeted 1 105 847 1 127 484 3 895 451 - -
Population treated 1 193 428 1 185 814 3 580 726 4 088 084 4 129 227
Geographical coverage 100% - -
Programme coverage 107.9% 105.2% 91.9% - -
Round 2
Population targeted 1 127 484
Population treated 1 158 318 2 094 325
Geographical coverage - -
Programme coverage 102.7%
○ Geographical coverage - proportion (%) of endemic districts covered with preventive chemotherapy
○ Programme coverage - proportion (%) of individuals who were treated as per the programme target
○ PreSAC- Pre-school Aged Children
○ SAC- School Aged Children
Table 3 Implementation of preventive chemotherapy in 2014 using ALB/MEB/PZQ against STHs and schistosomiasis among PreSAC
and SAC in Rwanda












Pre-SAC Round 1- Albendazole/mebendazole
STH 948,314 1,295,177 1,252,185 96.68% 100%
Round 2- Albendazole/mebendazole
948,314 1,295,177 1,241,007 95.82% 100%
School aged children Schistosomiasis/STH Round-1 Albendazole/Praziquantel
2,326,209 177,688 174,762 98.35% 7.51%
Round-2 Albendazole/mebendazole
2,326,209 3,177,065 3,026,425 95.26% 100%
Rujeni et al. Infectious Diseases of Poverty  (2017) 6:8 Page 9 of 11
infections. However, transmission is continuing in most of
the endemic districts resulting in re-infection of the
treated population. With mathematical models and ana-
lysis of the impact of climate change predicting an
increasing risk for schistosomiasis transmission in Rwanda
in the coming years [19], an integrated approach to con-
trol STHs and schistosomiasis is imperative.
The observed high cure rates and reduction in preva-
lence cannot be sustained only by MDA programmes
because these programmes do not modify the en-
vironment where transmission occurs. In addition, the
current MDA programme only focuses on a segment of
the population, that is PreSAC and SAC, and the other
segment of the population is not considered, that is,
adults who may serve as source of infection to treated
children. In addition, in endemic areas, re-infection fol-
lowing treatment occurs very rapidly because of poor
sanitation and hygienic practices, and this necessitates
re-treatment over a short period of time. Thus, in-
tegrating other public health measures into the MDA
programme will ensure maintenance of the prevalence
of these infections at a low level of transmission after
MDA, resulting in a subsequent reduction in re-
infection rates.
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